From Metastatic Melanoma to Immune Engineering with Antoni Ribas, MD, PhD

Antoni Ribas, MD, PhD, is a pioneering figure in cancer immunotherapy whose work has transformed our understanding of metastatic melanoma and laid the groundwork for the emerging field of immune engineering. As Director of the PICI Center at UCLA, Professor of Medicine at the David Geffen School of Medicine at UCLA, and Director of the Tumor Immunology Program at the UCLA Health Jonsson Comprehensive Cancer Center, Dr. Ribas has driven major breakthroughs in immune checkpoint inhibitors and cellular therapies.

In this episode of From Bench to Fireside, Dr. Ribas joins PICI Chief Scientific Officer John Connolly, PhD, for an in-depth discussion on:

• His journey from early work in metastatic melanoma to advancing novel immune engineering strategies
• The evolution of immunotherapy, with a special focus on his groundbreaking contributions to immune checkpoint inhibitors
• The potential of multiplex trials to drive future breakthroughs in cancer treatment
• How collaborative research is shaping the future of oncology
• His insights on mentoring the next generation of researchers

.

🎧 Listen now:
→ Apple Podcasts
→ Spotify